ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called ...

Zantac went on sale in the UK in 1981. But in 2019, GSK withdrew it in the UK and US over fears that the ingredient ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

GSK (GSK) plc announced a new research collaboration with the UK Dementia Research Institute and Health Data Research UK to advance ...

GSK partners with UK research groups to study if Shingrix shingles vaccine reduces dementia risk, analyzing NHS data from ...

GSK shares are trading cheaply and offering potential passive income. So is this FTSE 100 stock a no-brainer buy for my ...

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...

To rub salt in the wound, rival AstraZeneca has grown into the UK’s biggest company under CEO Pascal Soriot’s leadership. Its market cap is now £180bn, three times the size of GSK’s.

GlaxoSmithKline is to sell off its famous bedtime malted milk drink Horlicks in the UK, and will also consider exiting a pharma business, its cephalosporins antibiotics franchise.